ARCHIVES

FCRF Contracts Recompetition Will Be Along Same Lines As in 1982 But for at Least Seven Years

This article is from The Cancer Letter archive.

Vol. 11 No. 27 | July 5, 1985

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

July 27, 2007

Centers Urged To Apply For Comprehensive Status By June 1

February 16, 1990

Oral Sorafenib Trial Published in The Lancet; Tablets Extend PFS in Metastatic Disease

April 25, 2014

ACS Concludes That Laetrile Organization Is Insignificant

November 29, 1991

Historical Vs. Current Controls: Comparability, Ethical Issues Argued By Moertel, Freireich

April 20, 1979

High Risk Youth Targeted In Concept Ok’d By Advisors

February 8, 1991